1	INTRODUCTION	39 
1.1	STUDY OBJECTIVES	39 
1.2	MARKET DEFINITION	39 
1.2.1	INCLUSIONS AND EXCLUSIONS	40 
1.3	MARKET SEGMENTATION	41 
1.3.1	REGIONAL SEGMENTATION	41 
1.3.2	YEARS CONSIDERED	42 
1.3.3	CURRENCY CONSIDERED	42 
1.4	STAKEHOLDERS	42 
1.5	LIMITATIONS	43 
1.5.1	SCOPE-RELATED LIMITATIONS	43 
1.5.2	METHODOLOGY-RELATED LIMITATIONS	43 
1.6	SUMMARY OF CHANGES	43 
1.7	RECESSION IMPACT	44 
2	RESEARCH METHODOLOGY	45 
2.1	RESEARCH DATA	45 
FIGURE 1	RESEARCH DESIGN	45 
2.1.1	SECONDARY DATA	46 
2.1.1.1	Key data from secondary sources	46 
2.1.2	PRIMARY DATA	47 
FIGURE 2	PRIMARY SOURCES	47 
2.1.2.1	Key data from primary sources	48 
FIGURE 3	INSIGHTS FROM INDUSTRY EXPERTS	48 
2.1.2.2	Breakdown of primary sources	49 
FIGURE 4	BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION	49 
2.2	MARKET SIZE ESTIMATION	49 
FIGURE 5	RESEARCH METHODOLOGY: HYPOTHESIS BUILDING	50 
FIGURE 6	REMOTE PATIENT MONITORING MARKET: ESTIMATION OF MARKET SIZE THROUGH ADOPTION-BASED APPROACH	51 
FIGURE 7	CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023–2028)	53 
FIGURE 8	CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS	54 
FIGURE 9	TOP-DOWN APPROACH	54 
TABLE 1	IMPACT ANALYSIS	55 
2.3	MARKET BREAKDOWN AND DATA TRIANGULATION	56 
FIGURE 10	DATA TRIANGULATION METHODOLOGY	56 
2.4	STUDY ASSUMPTIONS	57 
2.5	RISK ASSESSMENT	57 
TABLE 2	RISK ASSESSMENT ANALYSIS	57 
2.6	RECESSION IMPACT ANALYSIS	58 
3	EXECUTIVE SUMMARY	59 
FIGURE 11	REMOTE PATIENT MONITORING MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)	59 
FIGURE 12	REMOTE PATIENT MONITORING MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)	60 
FIGURE 13	REMOTE PATIENT MONITORING MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)	60 
FIGURE 14	GEOGRAPHIC SNAPSHOT OF REMOTE PATIENT MONITORING MARKET	61 
4	PREMIUM INSIGHTS	62 
4.1	REMOTE PATIENT MONITORING MARKET OVERVIEW	62 
FIGURE 15	RISING POPULATION AND GROWING FOCUS ON EXPANDING HEALTHCARE TO DRIVE MARKET DURING FORECAST PERIOD	62 
4.2	ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY TYPE AND COUNTRY (2022)	63 
FIGURE 16	SOFTWARE & SERVICES SEGMENT IN CHINA ACCOUNTED FOR LARGEST MARKET SHARE IN 2022	63 
4.3	REMOTE PATIENT MONITORING MARKET: GEOGRAPHIC MIX	64 
FIGURE 17	CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD	64 
4.4	REMOTE PATIENT MONITORING MARKET: DEVELOPED VS. EMERGING MARKETS	64 
FIGURE 18	EMERGING MARKETS TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD	64 
5	MARKET OVERVIEW	65 
5.1	INTRODUCTION	65 
FIGURE 19	REMOTE PATIENT MONITORING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES	65 
5.2	DRIVERS	66 
5.2.1	GROWTH IN POPULATION AND SUBSEQUENT NEED TO EXPAND HEALTHCARE ACCESS	66 
5.2.2	COST BENEFITS OF TELEHEALTH	66 
TABLE 3	CHRONIC DISEASES AND COST BURDEN IN US: POTENTIAL SAVINGS	67 
5.2.3	ABILITY TO REDUCE BURDEN ON MEDICAL RESOURCES	67 
5.2.4	ADVANCEMENTS IN TELECOMMUNICATION	67 
5.2.5	RISING INVESTMENTS IN TELEHEALTH SOLUTIONS	68 
5.3	RESTRAINTS	68 
5.3.1	VARIABLE REGULATORY STANDARDS ACROSS REGIONAL MARKETS	68 
TABLE 4	US: STATE-WISE REGULATORY REQUIREMENTS FOR TELEHEALTH	69 
5.3.2	HEALTHCARE FRAUD	70 
5.3.3	INFORMAL USAGE OF SOCIAL MEDIA FOR HEALTHCARE PRACTICES	70 
5.4	OPPORTUNITIES	70 
5.4.1	IMPACT OF AI ON REMOTE PATIENT MONITORING	70 
5.4.2	HIGH UTILIZATION IN INFECTIOUS DISEASE MONITORING	71 
5.5	CHALLENGES	72 
5.5.1	BEHAVIORAL BARRIERS AND HEALTHCARE AFFORDABILITY	72 
5.5.2	DATA ACCESSIBILITY ISSUES	72 
5.6	INDUSTRY TRENDS	72 
5.6.1	GRADUAL SHIFT TO VALUE-BASED AND PATIENT-CENTRIC CARE	72 
5.6.2	INNOVATIONS IN WEARABLE MEDICAL TECHNOLOGY	73 
5.7	TARIFF AND REGULATORY ANALYSIS	74 
5.7.1	TARIFF FOR REMOTE PATIENT MONITORING DEVICES	74 
5.7.2	REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS	74 
TABLE 5	LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS	74 
5.7.3	NORTH AMERICA	75 
5.7.3.1	US	75 
TABLE 6	US: CLASSIFICATION OF MEDICAL EQUIPMENT	75 
TABLE 7	US: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS	75 
5.7.3.2	Canada	75 
TABLE 8	CANADA: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS	75 
5.7.3.3	Europe	76 
TABLE 9	EUROPE: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS	76 
5.7.3.4	Asia Pacific	76 
5.7.3.4.1	Japan	76 
TABLE 10	JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS	77 
5.7.3.4.2	China	77 
TABLE 11	CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS	78 
5.7.3.4.3	India	78 
5.8	ECOSYSTEM ANALYSIS	78 
FIGURE 20	REMOTE PATIENT MONITORING MARKET: ECOSYSTEM ANALYSIS	79 
5.9	VALUE CHAIN ANALYSIS	79 
FIGURE 21	REMOTE PATIENT MONITORING MARKET: VALUE CHAIN ANALYSIS	80 
5.10	TECHNOLOGY ANALYSIS	80 
5.10.1	REMOTE PATIENT MONITORING MARKET: DIGITAL TECHNOLOGY ENABLERS, BENEFITS, AND EXAMPLES	80 
5.11	PATENT ANALYSIS	81 
5.11.1	PATENT PUBLICATION TRENDS	81 
FIGURE 22	PATENT PUBLICATION TRENDS: JANUARY 2011−SEPTEMBER 2023	82 
5.11.2	JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR REMOTE PATIENT MONITORING PATENTS (2011−2023)	82 
TABLE 12	JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR REMOTE PATIENT MONITORING PATENTS	82 
5.11.3	REMOTE PATIENT MONITORING MARKET: TOP APPLICANTS	83 
FIGURE 23	TOP APPLICANTS FOR REMOTE PATIENT MONITORING PATENTS (2011–2023)	83 
5.11.4	REMOTE PATIENT MONITORING MARKET: LIST OF PATENTS/PATENT APPLICATIONS	83 
5.12	TRADE ANALYSIS	84 
5.12.1	TRADE ANALYSIS FOR REMOTE PATIENT MONITORING DEVICES	85 
FIGURE 24	IMPORT OF PRODUCTS UNDER HSN CODE: 90189099, BY COUNTRY, 2022 (USD THOUSAND)	85 
FIGURE 25	EXPORTS OF PRODUCTS UNDER HSN CODE: 90189099, BY COUNTRY, 2022 (USD THOUSAND)	85 
5.13	CASE STUDY ANALYSIS	86 
TABLE 13	CASE STUDY 1: INTEGRATION OF GARMIN WEARABLE DEVICE DATA INTO MEDTRONIC CARE MANAGEMENT SERVICES (MCMS) RPM PLATFORM	86 
TABLE 14	CASE STUDY 2: MOTION-SENSOR TECHNOLOGY FOR EARLY DETECTION OF CVD	86 
5.14	PORTER’S FIVE FORCES ANALYSIS	87 
TABLE 15	REMOTE PATIENT MONITORING MARKET: PORTER’S FIVE FORCES ANALYSIS	87 
5.14.1	THREAT OF NEW ENTRANTS	87 
5.14.2	THREAT OF SUBSTITUTES	88 
5.14.3	BARGAINING POWER OF MANUFACTURERS	88 
5.14.4	BARGAINING POWER OF BUYERS	88 
5.14.5	INTENSITY OF COMPETITIVE RIVALRY	88 
5.15	KEY CONFERENCES AND EVENTS	89 
5.15.1	LIST OF KEY CONFERENCES AND EVENTS (2023−2024)	89 
5.16	KEY STAKEHOLDERS AND BUYING CRITERIA	90 
5.16.1	KEY STAKEHOLDERS IN BUYING PROCESS	90 
TABLE 16	INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR REMOTE PATIENT MONITORING	90 
TABLE 17	INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR REMOTE PATIENT MONITORING, BY TYPE	91 
5.16.2	BUYING CRITERIA	91 
FIGURE 26	KEY BUYING CRITERIA FOR REMOTE PATIENT MONITORING, BY TYPE	91 
TABLE 18	KEY BUYING CRITERIA FOR REMOTE PATIENT MONITORING	91 
5.17	PRICING ANALYSIS	92 
TABLE 19	AVERAGE SELLING PRICE FOR REMOTE PATIENT MONITORING DEVICES, BY KEY PLAYERS (2022)	92 
TABLE 20	AVERAGE SELLING PRICE FOR REMOTE PATIENT MONITORING DEVICES, BY KEY DEVICES (2022)	93 
TABLE 21	INDICATIVE PRICING ANALYSIS OF REMOTE PATIENT MONITORING DEVICES, BY REGION, 2021 (USD)	93 
5.18	REMOTE PATIENT MONITORING MARKET: UNMET NEEDS ANALYSIS	94 
TABLE 22	UNMET NEEDS IN REMOTE PATIENT MONITORING MARKET	94 
5.18.1	REMOTE PATIENT MONITORING MARKET: END-USER EXPECTATIONS	94 
TABLE 23	END-USER EXPECTATIONS IN REMOTE PATIENT MONITORING MARKET	95 
5.19	REIMBURSEMENT SCENARIO	96 
TABLE 24	CPT CODES AND REIMBURSEMENT ANALYSIS OF US RPM MARKET	96 
5.20	TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES	97 
5.20.1	REVENUE SHIFTS AND NEW REVENUE POCKETS FOR REMOTE PATIENT MONITORING MARKET	97 
6	REMOTE PATIENT MONITORING MARKET, BY TYPE	98 
6.1	INTRODUCTION	99 
TABLE 25	REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021–2028 (USD MILLION)	99 
6.2	SOFTWARE & SERVICES	99 
6.2.1	AVAILABILITY OF REIMBURSEMENTS FOR RPM SERVICES TO PROPEL MARKET	99 
TABLE 26	REMOTE PATIENT MONITORING MARKET FOR SOFTWARE & SERVICES, BY REGION, 2021–2028 (USD MILLION)	100 
TABLE 27	NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE & SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)	101 
TABLE 28	EUROPE: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE & SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)	101 
TABLE 29	ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE & SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)	102 
TABLE 30	LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE & SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)	102 
6.3	DEVICES	102 
TABLE 31	REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)	103 
TABLE 32	REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY REGION, 2021–2028 (USD MILLION)	104 
TABLE 33	NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)	104 
TABLE 34	EUROPE: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)	105 
TABLE 35	ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)	105 
TABLE 36	LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)	106 
6.3.1	CARDIAC MONITORING DEVICES	106 
TABLE 37	REMOTE PATIENT MONITORING MARKET FOR CARDIAC MONITORING DEVICES, BY REGION, 2021–2028 (USD MILLION)	107 
TABLE 38	NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR CARDIAC MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)	107 
TABLE 39	EUROPE: REMOTE PATIENT MONITORING MARKET FOR CARDIAC MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)	108 
TABLE 40	ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR CARDIAC MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)	108 
TABLE 41	LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR CARDIAC MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)	109 
TABLE 42	REMOTE PATIENT MONITORING MARKET FOR CARDIAC MONITORING DEVICES, BY TYPE, 2021–2028 (USD MILLION)	109 
6.3.1.1	BLOOD PRESSURE MONITORING DEVICES	109 
6.3.1.1.1	Growing preference for wearable smartphone-connected devices to boost demand	109 
TABLE 43	REMOTE PATIENT MONITORING MARKET FOR BLOOD PRESSURE MONITORING DEVICES, BY REGION, 2021–2028 (USD MILLION)	110 
6.3.2	NEUROLOGICAL MONITORING DEVICES	110 
6.3.2.1	Rising cases of epilepsy and Alzheimer’s to support market growth	110 
TABLE 44	REMOTE PATIENT MONITORING MARKET FOR NEUROLOGICAL MONITORING DEVICES, BY REGION, 2021–2028 (USD MILLION)	111 
TABLE 45	NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR NEUROLOGICAL MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)	111 
TABLE 46	EUROPE: REMOTE PATIENT MONITORING MARKET FOR NEUROLOGICAL MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)	112 
TABLE 47	ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR NEUROLOGICAL MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)	112 
TABLE 48	LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR NEUROLOGICAL MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)	113 
6.3.3	RESPIRATORY MONITORING DEVICES	113 
6.3.3.1	Growing adoption of pulse oximeters to drive market	113 
TABLE 49	REMOTE PATIENT MONITORING MARKET FOR RESPIRATORY MONITORING DEVICES, BY REGION, 2021–2028 (USD MILLION)	114 
TABLE 50	NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR RESPIRATORY MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)	114 
TABLE 51	EUROPE: REMOTE PATIENT MONITORING MARKET FOR RESPIRATORY MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)	115 
TABLE 52	ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR RESPIRATORY MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)	115 
TABLE 53	LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR RESPIRATORY MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)	116 
6.3.4	MULTIPARAMETER MONITORING DEVICES	116 
6.3.4.1	Ability to measure multi-physiological and biochemical ranges to boost demand	116 
TABLE 54	REMOTE PATIENT MONITORING MARKET FOR MULTIPARAMETER MONITORING DEVICES, BY REGION, 2021–2028 (USD MILLION)	117 
TABLE 55	NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR MULTIPARAMETER MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)	117 
TABLE 56	EUROPE: REMOTE PATIENT MONITORING MARKET FOR MULTIPARAMETER MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)	118 
TABLE 57	ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR MULTIPARAMETER MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)	118 
TABLE 58	LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR MULTIPARAMETER MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)	119 
6.3.5	BLOOD GLUCOSE MONITORING DEVICES	119 
6.3.5.1	High incidence of diabetes to drive market	119 
TABLE 59	REMOTE PATIENT MONITORING MARKET FOR BLOOD GLUCOSE MONITORING DEVICES, BY REGION, 2021–2028 (USD MILLION)	120 
TABLE 60	NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR BLOOD GLUCOSE MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)	120 
TABLE 61	EUROPE: REMOTE PATIENT MONITORING MARKET FOR BLOOD GLUCOSE MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)	121 
TABLE 62	ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR BLOOD GLUCOSE MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)	121 
TABLE 63	LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR BLOOD GLUCOSE MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)	122 
6.3.6	FETAL & NEONATAL MONITORING DEVICES	122 
6.3.6.1	Rising number of preterm births to propel market for RPM devices	122 
TABLE 64	REMOTE PATIENT MONITORING MARKET FOR FETAL & NEONATAL MONITORING DEVICES, BY REGION, 2021–2028 (USD MILLION)	123 
TABLE 65	NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR FETAL & NEONATAL MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)	123 
TABLE 66	EUROPE: REMOTE PATIENT MONITORING MARKET FOR FETAL & NEONATAL MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)	124 
TABLE 67	ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR FETAL & NEONATAL MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)	124 
TABLE 68	LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR FETAL & NEONATAL MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)	125 
6.3.7	WEIGHT MONITORING DEVICES	125 
6.3.7.1	Rising obesity levels to fuel uptake	125 
TABLE 69	REMOTE PATIENT MONITORING MARKET FOR WEIGHT MONITORING DEVICES, BY REGION, 2021–2028 (USD MILLION)	126 
TABLE 70	NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR WEIGHT MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)	126 
TABLE 71	EUROPE: REMOTE PATIENT MONITORING MARKET FOR WEIGHT MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)	127 
TABLE 72	ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR WEIGHT MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)	127 
TABLE 73	LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR WEIGHT MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)	128 
6.3.8	OTHER MONITORING DEVICES	128 
TABLE 74	REMOTE PATIENT MONITORING MARKET FOR OTHER MONITORING DEVICES, BY REGION, 2021–2028 (USD MILLION)	129 
TABLE 75	NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR OTHER MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)	129 
TABLE 76	EUROPE: REMOTE PATIENT MONITORING MARKET FOR OTHER MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)	130 
TABLE 77	ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR OTHER MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)	130 
TABLE 78	LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR OTHER MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)	131 
7	REMOTE PATIENT MONITORING MARKET, BY APPLICATION	132 
7.1	INTRODUCTION	133 
TABLE 79	REMOTE PATIENT MONITORING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)	133 
7.2	ONCOLOGY	133 
7.2.1	RISING INCIDENCE OF CANCER TO PROPEL MARKET	133 
TABLE 80	REMOTE PATIENT MONITORING MARKET FOR ONCOLOGY, BY REGION, 2021–2028 (USD MILLION)	134 
TABLE 81	NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR ONCOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)	134 
TABLE 82	EUROPE: REMOTE PATIENT MONITORING MARKET FOR ONCOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)	135 
TABLE 83	ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR ONCOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)	135 
TABLE 84	LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR ONCOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)	136 
7.3	CARDIOVASCULAR DISEASES	136 
7.3.1	HIGH INCIDENCE OF CVD TO SUPPORT MARKET GROWTH	136 
TABLE 85	REMOTE PATIENT MONITORING MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2021–2028 (USD MILLION)	136 
TABLE 86	NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)	137 
TABLE 87	EUROPE: REMOTE PATIENT MONITORING MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)	137 
TABLE 88	ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)	137 
TABLE 89	LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)	138 
7.4	DIABETES	138 
7.4.1	TECHNOLOGICAL ADVANCEMENTS IN WEARABLE MONITORS TO BOOST DEMAND	138 
TABLE 90	REMOTE PATIENT MONITORING MARKET FOR DIABETES, BY REGION, 2021–2028 (USD MILLION)	139 
TABLE 91	NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR DIABETES, BY COUNTRY, 2021–2028 (USD MILLION)	139 
TABLE 92	EUROPE: REMOTE PATIENT MONITORING MARKET FOR DIABETES, BY COUNTRY, 2021–2028 (USD MILLION)	140 
TABLE 93	ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR DIABETES, BY COUNTRY, 2021–2028 (USD MILLION)	140 
TABLE 94	LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR DIABETES, BY COUNTRY, 2021–2028 (USD MILLION)	141 
7.5	SLEEP DISORDERS	141 
7.5.1	WIDE UTILIZATION IN SLEEP APNEA MANAGEMENT TO PROPEL MARKET	141 
TABLE 95	REMOTE PATIENT MONITORING MARKET FOR SLEEP DISORDERS, BY REGION, 2021–2028 (USD MILLION)	142 
TABLE 96	NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR SLEEP DISORDERS, BY COUNTRY, 2021–2028 (USD MILLION)	142 
TABLE 97	EUROPE REMOTE PATIENT MONITORING MARKET FOR SLEEP DISORDERS, BY COUNTRY, 2021–2028 (USD MILLION)	143 
TABLE 98	ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR SLEEP DISORDERS, BY COUNTRY, 2021–2028 (USD MILLION)	143 
TABLE 99	LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR SLEEP DISORDERS, BY COUNTRY, 2021–2028 (USD MILLION)	144 
7.6	WEIGHT MANAGEMENT AND FITNESS MONITORING	144 
7.6.1	CHRONIC DISEASE MANAGEMENT TO SUPPORT MARKET GROWTH	144 
TABLE 100	REMOTE PATIENT MONITORING MARKET FOR WEIGHT MANAGEMENT AND FITNESS MONITORING, BY REGION, 2021–2028 (USD MILLION)	145 
TABLE 101	NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR WEIGHT MANAGEMENT AND FITNESS MONITORING, BY COUNTRY, 2021–2028 (USD MILLION)	145 
TABLE 102	EUROPE: REMOTE PATIENT MONITORING MARKET FOR WEIGHT MANAGEMENT AND FITNESS MONITORING, BY COUNTRY, 2021–2028 (USD MILLION)	146 
TABLE 103	ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR WEIGHT MANAGEMENT & FITNESS MONITORING, BY COUNTRY, 2021–2028 (USD MILLION)	146 
TABLE 104	LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR WEIGHT MANAGEMENT AND FITNESS MONITORING, BY COUNTRY, 2021–2028 (USD MILLION)	147 
7.7	OTHER APPLICATIONS	147 
TABLE 105	REMOTE PATIENT MONITORING MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)	148 
TABLE 106	NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)	148 
TABLE 107	EUROPE: REMOTE PATIENT MONITORING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)	149 
TABLE 108	ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)	149 
TABLE 109	LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)	150 
8	REMOTE PATIENT MONITORING MARKET, BY END USER	151 
8.1	INTRODUCTION	152 
TABLE 110	REMOTE PATIENT MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)	152 
8.2	PROVIDERS	152 
TABLE 111	REMOTE PATIENT MONITORING MARKET FOR PROVIDERS, BY TYPE, 2021–2028 (USD MILLION)	153 
TABLE 112	REMOTE PATIENT MONITORING MARKET FOR PROVIDERS, BY REGION, 2021–2028 (USD MILLION)	154 
TABLE 113	NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION)	154 
TABLE 114	EUROPE: REMOTE PATIENT MONITORING MARKET FOR PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION)	155 
TABLE 115	ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION)	155 
TABLE 116	LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION)	156 
8.2.1	HOSPITALS AND CLINICS	156 
8.2.1.1	High incidence of infectious diseases to boost demand	156 
TABLE 117	REMOTE PATIENT MONITORING MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2021–2028 (USD MILLION)	157 
TABLE 118	NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2021–2028 (USD MILLION)	157 
TABLE 119	EUROPE: REMOTE PATIENT MONITORING MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2021–2028 (USD MILLION)	158 
TABLE 120	ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2021–2028 (USD MILLION)	158 
TABLE 121	LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2021–2028 (USD MILLION)	159 
8.2.2	HOME CARE SETTINGS AND LONG-TERM CARE CENTERS	159 
8.2.2.1	Advancements in wearable health technology to support market growth	159 
TABLE 122	REMOTE PATIENT MONITORING MARKET FOR HOME CARE SETTINGS AND LONG-TERM CARE CENTERS, BY REGION, 2021–2028 (USD MILLION)	160 
TABLE 123	NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR HOME CARE SETTINGS AND LONG-TERM CARE CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)	160 
TABLE 124	EUROPE: REMOTE PATIENT MONITORING MARKET FOR HOME CARE SETTINGS AND LONG-TERM CARE CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)	161 
TABLE 125	ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR HOME CARE SETTINGS AND LONG-TERM CARE CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)	161 
TABLE 126	LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR HOME CARE SETTINGS AND LONG-TERM CARE CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)	162 
8.2.3	AMBULATORY CARE CENTERS	162 
8.2.3.1	Gradual shift to outpatient settings to propel market	162 
TABLE 127	REMOTE PATIENT MONITORING MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2021–2028 (USD MILLION)	163 
TABLE 128	NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)	163 
TABLE 129	EUROPE: REMOTE PATIENT MONITORING MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)	164 
TABLE 130	ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)	164 
TABLE 131	LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)	165 
8.2.4	OTHER PROVIDERS	165 
TABLE 132	REMOTE PATIENT MONITORING MARKET FOR OTHER PROVIDERS, BY REGION, 2021–2028 (USD MILLION)	165 
TABLE 133	NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR OTHER PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION)	166 
TABLE 134	EUROPE: REMOTE PATIENT MONITORING MARKET FOR OTHER PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION)	166 
TABLE 135	ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR OTHER PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION)	167 
TABLE 136	LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR OTHER PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION)	167 
8.3	PAYERS	167 
8.3.1	INCREASING REIMBURSEMENTS FOR RPM SOLUTIONS TO PROPEL MARKET	167 
TABLE 137	REMOTE PATIENT MONITORING MARKET FOR PAYERS, BY REGION, 2021–2028 (USD MILLION)	168 
TABLE 138	NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR PAYERS, BY COUNTRY, 2021–2028 (USD MILLION)	168 
TABLE 139	EUROPE: REMOTE PATIENT MONITORING MARKET FOR PAYERS, BY COUNTRY, 2021–2028 (USD MILLION)	169 
TABLE 140	ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR PAYERS, BY COUNTRY, 2021–2028 (USD MILLION)	169 
TABLE 141	LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR PAYERS, BY COUNTRY, 2021–2028 (USD MILLION)	170 
8.4	PATIENTS	170 
8.4.1	COST-BENEFITS AND CONVENIENCE OFFERED BY RPM TO SUPPORT MARKET	170 
TABLE 142	REMOTE PATIENT MONITORING MARKET FOR PATIENTS, BY REGION, 2021–2028 (USD MILLION)	171 
TABLE 143	NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR PATIENTS, BY COUNTRY, 2021–2028 (USD MILLION)	171 
TABLE 144	EUROPE: REMOTE PATIENT MONITORING MARKET FOR PATIENTS, BY COUNTRY, 2021–2028 (USD MILLION)	172 
TABLE 145	ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR PATIENTS, BY COUNTRY, 2021–2028 (USD MILLION)	172 
TABLE 146	LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR PATIENTS, BY COUNTRY, 2021–2028 (USD MILLION)	173 
8.5	OTHER END USERS	173 
TABLE 147	REMOTE PATIENT MONITORING MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION)	174 
TABLE 148	NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)	174 
TABLE 149	EUROPE: REMOTE PATIENT MONITORING MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)	175 
TABLE 150	ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)	175 
TABLE 151	LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)	176 
9	REMOTE PATIENT MONITORING MARKET, BY REGION	177 
9.1	INTRODUCTION	178 
TABLE 152	REMOTE PATIENT MONITORING MARKET, BY REGION, 2021–2028 (USD MILLION)	178 
9.2	NORTH AMERICA	178 
FIGURE 27	NORTH AMERICA: REMOTE PATIENT MONITORING MARKET SNAPSHOT	179 
9.2.1	NORTH AMERICA: RECESSION IMPACT	179 
TABLE 153	NORTH AMERICA: REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)	180 
TABLE 154	NORTH AMERICA: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021–2028 (USD MILLION)	180 
TABLE 155	NORTH AMERICA: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)	181 
TABLE 156	NORTH AMERICA: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)	182 
TABLE 157	NORTH AMERICA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)	182 
TABLE 158	NORTH AMERICA: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021–2028 (USD MILLION)	183 
9.2.2	US	183 
9.2.2.1	High healthcare expenditure to boost demand for RPM services	183 
TABLE 159	US: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021–2028 (USD MILLION)	184 
TABLE 160	US: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)	185 
TABLE 161	US: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)	185 
TABLE 162	US: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)	186 
TABLE 163	US: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021–2028 (USD MILLION)	186 
9.2.3	CANADA	187 
9.2.3.1	Rising incidence of CVD to support market growth	187 
TABLE 164	CANADA: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021–2028 (USD MILLION)	187 
TABLE 165	CANADA: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)	188 
TABLE 166	CANADA: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)	188 
TABLE 167	CANADA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)	189 
TABLE 168	CANADA: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021–2028 (USD MILLION)	189 
9.3	EUROPE	190 
9.3.1	EUROPE: RECESSION IMPACT	190 
TABLE 169	EUROPE: REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)	191 
TABLE 170	EUROPE: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021–2028 (USD MILLION)	191 
TABLE 171	EUROPE: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)	192 
TABLE 172	EUROPE: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)	192 
TABLE 173	EUROPE: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)	193 
TABLE 174	EUROPE: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021–2028 (USD MILLION)	193 
9.3.2	GERMANY	194 
9.3.2.1	Rapid digitization of healthcare systems to drive market growth	194 
TABLE 175	GERMANY: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021–2028 (USD MILLION)	195 
TABLE 176	GERMANY: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)	195 
TABLE 177	GERMANY: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)	196 
TABLE 178	GERMANY: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)	196 
TABLE 179	GERMANY: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021–2028 (USD MILLION)	197 
9.3.3	UK	197 
9.3.3.1	Shortage of physicians to boost demand for telehealth solutions	197 
TABLE 180	UK: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021–2028 (USD MILLION)	198 
TABLE 181	UK: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)	198 
TABLE 182	UK: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)	199 
TABLE 183	UK: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)	199 
TABLE 184	UK: REMOTE PATIENT MONITORING MARKET FOR PROVIDERS, BY END USER, 2021–2028 (USD MILLION)	200 
9.3.4	FRANCE	200 
9.3.4.1	Favorable government initiatives for telehealth to support market growth	200 
TABLE 185	FRANCE: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021–2028 (USD MILLION)	201 
TABLE 186	FRANCE: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)	201 
TABLE 187	FRANCE: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)	202 
TABLE 188	FRANCE: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)	202 
TABLE 189	FRANCE: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021–2028 (USD MILLION)	203 
9.3.5	ITALY	203 
9.3.5.1	Growing focus on improvements in patient care to drive market	203 
TABLE 190	ITALY: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021–2028 (USD MILLION)	204 
TABLE 191	ITALY: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)	204 
TABLE 192	ITALY: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)	205 
TABLE 193	ITALY: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)	205 
TABLE 194	ITALY: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021–2028 (USD MILLION)	206 
9.3.6	SPAIN	206 
9.3.6.1	Rising incidence of chronic diseases to support market growth	206 
TABLE 195	SPAIN: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021–2028 (USD MILLION)	207 
TABLE 196	SPAIN: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)	207 
TABLE 197	SPAIN: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)	208 
TABLE 198	SPAIN: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)	208 
TABLE 199	SPAIN: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021–2028 (USD MILLION)	209 
9.3.7	REST OF EUROPE	209 
TABLE 200	REST OF EUROPE: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021–2028 (USD MILLION)	210 
TABLE 201	REST OF EUROPE: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)	210 
TABLE 202	REST OF EUROPE: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)	211 
TABLE 203	REST OF EUROPE: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)	211 
TABLE 204	REST OF EUROPE: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021–2028 (USD MILLION)	212 
9.4	ASIA PACIFIC	212 
FIGURE 28	ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET SNAPSHOT	213 
9.4.1	ASIA PACIFIC: RECESSION IMPACT	213 
TABLE 205	ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)	214 
TABLE 206	ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021–2028 (USD MILLION)	214 
TABLE 207	ASIA PACIFIC: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)	215 
TABLE 208	ASIA PACIFIC: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)	215 
TABLE 209	ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)	216 
TABLE 210	ASIA PACIFIC: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021–2028 (USD MILLION)	216 
9.4.2	CHINA	216 
9.4.2.1	High adoption of telemedicine to drive market	216 
TABLE 211	CHINA: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021–2028 (USD MILLION)	217 
TABLE 212	CHINA: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)	217 
TABLE 213	CHINA: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)	218 
TABLE 214	CHINA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)	218 
TABLE 215	CHINA: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021–2028 (USD MILLION)	219 
9.4.3	JAPAN	219 
9.4.3.1	Rising geriatric population and universal healthcare coverage to boost demand	219 
TABLE 216	JAPAN: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021–2028 (USD MILLION)	220 
TABLE 217	JAPAN: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)	220 
TABLE 218	JAPAN: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)	221 
TABLE 219	JAPAN: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)	221 
TABLE 220	JAPAN: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021–2028 (USD MILLION)	222 
9.4.4	INDIA	222 
9.4.4.1	Favorable government policies and high density of population in rural areas to propel market	222 
TABLE 221	INDIA: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021–2028 (USD MILLION)	223 
TABLE 222	INDIA: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)	224 
TABLE 223	INDIA: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)	224 
TABLE 224	INDIA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)	225 
TABLE 225	INDIA: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021–2028 (USD MILLION)	225 
9.4.5	REST OF ASIA PACIFIC	226 
TABLE 226	REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021–2028 (USD MILLION)	226 
TABLE 227	REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)	227 
TABLE 228	REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)	227 
TABLE 229	REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)	228 
TABLE 230	REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021–2028 (USD MILLION)	228 
9.5	LATIN AMERICA	229 
9.5.1	LATIN AMERICA: RECESSION IMPACT	229 
TABLE 231	LATIN AMERICA: REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)	229 
TABLE 232	LATIN AMERICA: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021–2028 (USD MILLION)	230 
TABLE 233	LATIN AMERICA: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)	230 
TABLE 234	LATIN AMERICA: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)	231 
TABLE 235	LATIN AMERICA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)	231 
TABLE 236	LATIN AMERICA: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021–2028 (USD MILLION)	232 
9.5.2	BRAZIL	232 
9.5.2.1	Rising adoption of telehealth solutions to support market growth	232 
TABLE 237	BRAZIL: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021–2028 (USD MILLION)	232 
TABLE 238	BRAZIL: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)	233 
TABLE 239	BRAZIL: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)	233 
TABLE 240	BRAZIL: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)	234 
TABLE 241	BRAZIL: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021–2028 (USD MILLION)	234 
9.5.3	MEXICO	235 
9.5.3.1	Improvements in healthcare infrastructure to boost demand	235 
TABLE 242	MEXICO: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021–2028 (USD MILLION)	235 
TABLE 243	MEXICO: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)	236 
TABLE 244	MEXICO: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)	236 
TABLE 245	MEXICO: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)	237 
TABLE 246	MEXICO: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021–2028 (USD MILLION)	237 
9.5.4	REST OF LATIN AMERICA	238 
TABLE 247	REST OF LATIN AMERICA: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021–2028 (USD MILLION)	238 
TABLE 248	REST OF LATIN AMERICA: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)	239 
TABLE 249	REST OF LATIN AMERICA: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)	239 
TABLE 250	REST OF LATIN AMERICA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)	240 
TABLE 251	REST OF LATIN AMERICA: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021–2028 (USD MILLION)	240 
9.6	MIDDLE EAST & AFRICA	241 
9.6.1	GOVERNMENT INITIATIVES FOR INVESTMENTS IN RPM SOLUTIONS TO SUPPORT MARKET GROWTH	241 
9.6.2	MIDDLE EAST & AFRICA: RECESSION IMPACT	241 
TABLE 252	MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021–2028 (USD MILLION)	242 
TABLE 253	MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)	242 
TABLE 254	MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)	243 
TABLE 255	MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)	243 
TABLE 256	MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021–2028 (USD MILLION)	244 
10	COMPETITIVE LANDSCAPE	245 
10.1	INTRODUCTION	245 
10.2	KEY PLAYER STRATEGIES	245 
TABLE 257	OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS (JANUARY 2020−OCTOBER 2023)	245 
10.3	REVENUE SHARE ANALYSIS	247 
FIGURE 29	REVENUE SHARE ANALYSIS OF KEY PLAYERS	247 
10.4	MARKET SHARE ANALYSIS	247 
FIGURE 30	REMOTE PATIENT MONITORING MARKET: RANKING OF KEY COMPANIES (2022)	248 
10.5	COMPANY EVALUATION MATRIX FOR KEY PLAYERS	249 
10.5.1	STARS	249 
10.5.2	EMERGING LEADERS	249 
10.5.3	PERVASIVE PLAYERS	249 
10.5.4	PARTICIPANTS	249 
FIGURE 31	REMOTE PATIENT MONITORING MARKET: COMPANY EVALUATION MATRIX (2022)	250 
10.5.5	COMPANY FOOTPRINT	251 
TABLE 258	REMOTE PATIENT MONITORING MARKET: OVERALL COMPANY FOOTPRINT	251 
TABLE 259	REMOTE PATIENT MONITORING MARKET: TYPE FOOTPRINT	252 
TABLE 260	REMOTE PATIENT MONITORING MARKET: APPLICATION FOOTPRINT	253 
TABLE 261	REMOTE PATIENT MONITORING MARKET: END-USER FOOTPRINT	254 
TABLE 262	REMOTE PATIENT MONITORING MARKET: REGIONAL FOOTPRINT	255 
10.6	START-UP/SME EVALUATION MATRIX	256 
10.6.1	PROGRESSIVE COMPANIES	256 
10.6.2	RESPONSIVE COMPANIES	256 
10.6.3	DYNAMIC COMPANIES	256 
10.6.4	STARTING BLOCKS	256 
FIGURE 32	REMOTE PATIENT MONITORING MARKET: START-UP/SME EVALUATION MATRIX (2022)	257 
10.6.5	COMPETITIVE BENCHMARKING	257 
TABLE 263	REMOTE PATIENT MONITORING MARKET: DETAILED LIST OF KEY START-UPS/SMES	257 
10.7	COMPETITIVE SCENARIOS AND TRENDS	258 
10.7.1	PRODUCT LAUNCHES & APPROVALS	258 
TABLE 264	REMOTE PATIENT MONITORING MARKET: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–OCTOBER 2023)	258 
10.7.2	DEALS	258 
TABLE 265	REMOTE PATIENT MONITORING MARKET: KEY DEALS (JANUARY 2020−OCTOBER 2023)	258 
11	COMPANY PROFILES	260 
(Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)* 
11.1	KEY PLAYERS	260 
11.1.1	KONINKLIJKE PHILIPS N.V.	260 
TABLE 266	KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW	260 
FIGURE 33	KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022)	261 
11.1.2	MEDTRONIC PLC	265 
TABLE 267	MEDTRONIC PLC: BUSINESS OVERVIEW	265 
FIGURE 34	MEDTRONIC PLC: COMPANY SNAPSHOT (2022)	266 
11.1.3	OMRON HEALTHCARE, INC.	271 
TABLE 268	OMRON HEALTHCARE, INC.: BUSINESS OVERVIEW	271 
FIGURE 35	OMRON HEALTHCARE, INC.: COMPANY SNAPSHOT (2022)	272 
11.1.4	BOSTON SCIENTIFIC CORPORATION	276 
TABLE 269	BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW	276 
FIGURE 36	BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2022)	277 
11.1.5	GE HEALTHCARE	279 
TABLE 270	GE HEALTHCARE: BUSINESS OVERVIEW	279 
FIGURE 37	GE HEALTHCARE: COMPANY SNAPSHOT (2022)	280 
11.1.6	ABBOTT LABORATORIES	283 
TABLE 271	ABBOTT LABORATORIES: BUSINESS OVERVIEW	283 
FIGURE 38	ABBOTT LABORATORIES: COMPANY SNAPSHOT (2022)	284 
11.1.7	ORACLE	286 
TABLE 272	ORACLE: BUSINESS OVERVIEW	286 
FIGURE 39	ORACLE: COMPANY SNAPSHOT (2022)	287 
11.1.8	ALTEN CALSOFT LABS (SUBSIDIARY OF ALTEN GROUP)	289 
TABLE 273	ALTEN GROUP: BUSINESS OVERVIEW	289 
FIGURE 40	ALTEN GROUP: COMPANY SNAPSHOT (2022)	290 
11.1.9	SIEMENS HEALTHINEERS	291 
TABLE 274	SIEMENS HEALTHINEERS: BUSINESS OVERVIEW	291 
FIGURE 41	SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2022)	292 
11.1.10	CLEARARCH, INC.	293 
TABLE 275	CLEARARCH, INC.: BUSINESS OVERVIEW	293 
11.1.11	BIOBEAT	295 
TABLE 276	BIOBEAT: BUSINESS OVERVIEW	295 
11.1.12	VIVALNK, INC.	298 
TABLE 277	VIVALNK, INC.: BUSINESS OVERVIEW	298 
11.1.13	VITALCONNECT	300 
TABLE 278	VITALCONNECT: BUSINESS OVERVIEW	300 
11.1.14	VIVIFY HEALTH, INC.	302 
TABLE 279	VIVIFY HEALTH, INC.: BUSINESS OVERVIEW	302 
11.1.15	BARDY DIAGNOSTICS (SUBSIDIARY OF BAXTER)	303 
TABLE 280	BARDY DIAGNOSTICS: BUSINESS OVERVIEW	303 
11.1.16	BIOTRONIK SE & CO. KG	304 
TABLE 281	BIOTRONIK SE & CO.KG: BUSINESS OVERVIEW	304 
11.1.17	BROOK, INC.	305 
TABLE 282	BROOK, INC.: BUSINESS OVERVIEW	305 
11.1.18	BLUE SPARK TECHNOLOGIES, INC.	306 
TABLE 283	BLUE SPARK TECHNOLOGY, INC.: BUSINESS OVERVIEW	306 
11.2	OTHER PLAYERS	307 
11.2.1	WELCH ALLYN (SUBSIDIARY OF HILL-ROM SERVICES, INC.)	307 
11.2.2	HEALTHBEATS PTE LTD.	308 
11.2.3	ALIVECOR, INC.	308 
11.2.4	TYTOCARE LTD.	309 
11.2.5	TELADOC HEALTH, INC.	309 
11.2.6	IRHYTHM TECHNOLOGIES, INC.	310 
11.2.7	DEXCOM, INC.	310 
*Details on Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)* might not be captured in case of unlisted companies. 
12	APPENDIX	311 
12.1	DISCUSSION GUIDE	311 
12.2	KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL	314 
12.3	CUSTOMIZATION OPTIONS	316 
12.4	RELATED REPORTS	316 
12.5	AUTHOR DETAILS	317 |